Arimidex is a brand name of the drug anastrozole, a non-steroidal aromatase inhibitor used in the treatment of breast cancer in postmenopausal women. The drug was approved by the U.S. Food and Drug Administration (FDA) in 1995. Anastrozole is the active ingredient in Arimidex, and it works by blocking the production of estrogen in the body.
Arimidex is used to treat early and advanced stages of breast cancer in postmenopausal women. It is also used to treat women who have had their ovaries removed, as well as women with metastatic breast cancer. It is also used to reduce the risk of recurrence in postmenopausal women who have been treated for early stage breast cancer.
The history of the discovery of Arimidex dates back to the late 1980s. It was developed by the pharmaceutical company AstraZeneca, which is now known as AstraZeneca PLC. The drug was first approved in the United States in 1995 and has since been approved in many other countries.
The active ingredient in Arimidex is anastrozole, which is a non-steroidal aromatase inhibitor. Aromatase inhibitors are drugs that block the production of estrogen in the body. Anastrozole is also known by its other names, including Arimidex, Anastrol, Anastrozol, and Anastrozole.
In addition to anastrozole, Arimidex also contains the inactive ingredients magnesium stearate, microcrystalline cellulose, lactose monohydrate, and corn starch.
Arimidex has been studied in clinical trials and has been proven to be effective in treating early and advanced stages of breast cancer in postmenopausal women. Studies have also shown that Arimidex can reduce the risk of recurrence in postmenopausal women who have been treated for early stage breast cancer.
Arimidex is generally well tolerated and side effects are usually mild. Common side effects include hot flashes, joint pain, nausea, and fatigue. Less common side effects include bone pain, headache, and rash.
Arimidex is an effective treatment for breast cancer in postmenopausal women. It works by blocking the production of estrogen in the body, which can slow the growth of cancer cells. It is generally well tolerated and has been proven to be effective in treating early and advanced stages of breast cancer.
References:
1. National Cancer Institute. (2020). Anastrozole (Arimidex). Retrieved from https://www.cancer.gov/about-cancer/treatment/drugs/anastrozole
2. Mayo Clinic. (2020). Anastrozole (Arimidex). Retrieved from https://www.mayoclinic.org/drugs-supplements/anastrozole-oral-route/description/drg-20069976
3. U.S. National Library of Medicine. (2020). Anastrozole. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11593918